Matches in Wikidata for { <http://www.wikidata.org/entity/Q83040839> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q83040839 description "artículu científicu espublizáu n'abril de 2006" @default.
- Q83040839 description "im April 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83040839 description "scientific article published on 01 April 2006" @default.
- Q83040839 description "wetenschappelijk artikel" @default.
- Q83040839 description "наукова стаття, опублікована у квітні 2006" @default.
- Q83040839 name "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 name "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 type Item @default.
- Q83040839 label "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 label "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 prefLabel "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 prefLabel "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 P1433 Q83040839-6CB1A031-10C8-4F74-A8FA-27EDA75D45FE @default.
- Q83040839 P1476 Q83040839-839C4B15-8B8D-4932-B0E2-3EA0AFEE2635 @default.
- Q83040839 P2093 Q83040839-03B8CB96-35C4-4308-9692-8AACAD364F0E @default.
- Q83040839 P2093 Q83040839-7B059681-A237-4365-AB5B-0B3198222431 @default.
- Q83040839 P2093 Q83040839-837F4316-AC19-4E61-A982-4F2D91FBCCB3 @default.
- Q83040839 P2093 Q83040839-C3FF48E5-2BF3-4CA4-BCDA-2A2D545B991E @default.
- Q83040839 P304 Q83040839-A7ECEAD0-0DF2-4C76-8095-A070826D076F @default.
- Q83040839 P31 Q83040839-C65C2D77-2078-44B2-B8C7-F52C1A1C12D0 @default.
- Q83040839 P356 Q83040839-4FF2BA99-2A11-4BD3-A545-7010E354CBA6 @default.
- Q83040839 P433 Q83040839-B0F3728D-1CB8-4FA8-BBA9-DC6C9930FB0B @default.
- Q83040839 P478 Q83040839-6E64EAD2-C0C8-41F3-A45A-524D3951B7E9 @default.
- Q83040839 P577 Q83040839-0D6E547C-EA7D-4B7D-979B-4D0322F0E553 @default.
- Q83040839 P698 Q83040839-BA69C670-5905-4076-98CF-D3C3B38FD621 @default.
- Q83040839 P921 Q83040839-500274BB-6A9F-4F59-8704-DDD81A6CC62E @default.
- Q83040839 P356 J.OPHTHA.2006.01.027 @default.
- Q83040839 P698 16581423 @default.
- Q83040839 P1433 Q7098109 @default.
- Q83040839 P1476 "Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration" @default.
- Q83040839 P2093 "Gary Hantsbarger" @default.
- Q83040839 P2093 "Jeffrey S Heier" @default.
- Q83040839 P2093 "Naveed Shams" @default.
- Q83040839 P2093 "Philip J Rosenfeld" @default.
- Q83040839 P304 "623.e1" @default.
- Q83040839 P31 Q13442814 @default.
- Q83040839 P356 "10.1016/J.OPHTHA.2006.01.027" @default.
- Q83040839 P433 "4" @default.
- Q83040839 P478 "113" @default.
- Q83040839 P577 "2006-04-01T00:00:00Z" @default.
- Q83040839 P698 "16581423" @default.
- Q83040839 P921 Q27429789 @default.